{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:12:18Z","timestamp":1771866738964,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,6,8]],"date-time":"2013-06-08T00:00:00Z","timestamp":1370649600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00415-013-6987-y","type":"journal-article","created":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T07:33:09Z","timestamp":1370590389000},"page":"2163-2165","source":"Crossref","is-referenced-by-count":16,"title":["Changes in regulatory T cells after rituximab in two patients with refractory myasthenia gravis"],"prefix":"10.1007","volume":"260","author":[{"given":"Valentina","family":"Catzola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexia","family":"Buzzonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Scuderi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Fattorossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Evoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,8]]},"reference":[{"key":"6987_CR1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1600-065X.2010.00945.x","volume":"237","author":"MJ Townsend","year":"2010","unstructured":"Townsend MJ, Monroe JG, Chan AC (2010) B-cell targeted therapies in human autoimmune diseases: an update perspective. Immunol Rev 237:264\u2013283","journal-title":"Immunol Rev"},{"key":"6987_CR2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood-2007-12-129262","volume":"112","author":"R Stasi","year":"2008","unstructured":"Stasi R, Cooper N, Del Poeta G et al (2008) Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood 112:1147\u20131150","journal-title":"Blood"},{"key":"6987_CR3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clim.2006.12.006","volume":"123","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis PP, Souliotis VL, Fragiadaki KG et al (2007) Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin Immunol 123:66\u201373","journal-title":"Clin Immunol"},{"key":"6987_CR4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2005.02220.x","volume":"116","author":"A Fattorossi","year":"2005","unstructured":"Fattorossi A, Battaglia A, Buzzonetti A et al (2005) Circulating and thymic CD4+ CD25+ T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Immunology 116:134\u2013141","journal-title":"Immunology"},{"key":"6987_CR5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1749-6632.2012.06840.x","volume":"1274","author":"M Thiruppathi","year":"2012","unstructured":"Thiruppathi M, Rowin J, Li Jiang Q et al (2012) Functional defect in regulatory T cells in myasthenia gravis. Ann NY Acad Sci 1274:68\u201376","journal-title":"Ann NY Acad Sci"},{"key":"6987_CR6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8:475\u2013490","journal-title":"Lancet Neurol"},{"key":"6987_CR7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1756285611411503","volume":"4","author":"RJ Nowak","year":"2011","unstructured":"Nowak RJ, Dicapua DB, Zebardast N, Goldstein JM (2011) Response of patients with refractory myasthenia gravis to rituximab: a retrospective study. Ther Adv Neurol Disord 4:259\u2013266","journal-title":"Ther Adv Neurol Disord"},{"key":"6987_CR8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.0b013e3182407982","volume":"78","author":"J D\u00edaz-Manera","year":"2012","unstructured":"D\u00edaz-Manera J, Mart\u00ednez-Hern\u00e1ndez E, Querol L et al (2012) Long-lasting treatment effect of rituximab in MuSK myasthenia. Neurology 78:189\u2013193","journal-title":"Neurology"},{"key":"6987_CR9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16\u201323","journal-title":"Neurology"},{"key":"6987_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/imm.12061","volume":"139","author":"A Battaglia","year":"2012","unstructured":"Battaglia A, Buzzonetti A, Baranello C et al (2012) IL-21 synergises with IL-2 to enhance TCR-\u03b2-induced human T cell proliferation and counteracts IL-2\/TGF-\u03b2 induced regulatory T cell development. Immunology 139:109\u2013120","journal-title":"Immunology"},{"key":"6987_CR11","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/cncr.20130","volume":"100","author":"A Fattorossi","year":"2004","unstructured":"Fattorossi A, Battaglia A, Ferrandina G et al (2004) Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma. Cancer 100:1418\u20131428","journal-title":"Cancer"},{"key":"6987_CR12","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.27435","volume":"62","author":"A Khosroshahi","year":"2010","unstructured":"Khosroshahi A, Bloch DB, Deshpande V, Stone JH (2010) Rituximab therapy leads to rapid decline of serum IgG4 levels and prompts clinical improvement in IgG4-related systemic disease. Arthritis Rheum 62:1755\u20131762","journal-title":"Arthritis Rheum"},{"key":"6987_CR13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nri2729","volume":"10","author":"FE Lund","year":"2010","unstructured":"Lund FE, Randall TD (2010) Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol 10:236\u2013247","journal-title":"Nat Rev Immunol"},{"key":"6987_CR14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/CDLI.8.2.303-313.2001","volume":"8","author":"J Baran","year":"2001","unstructured":"Baran J, Kowalczyk D, Oz\u00f3g M, Zembala M (2001) Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation. Clin Diagn Lab Immunol 8:303\u2013313","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-6987-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-013-6987-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-6987-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T23:50:21Z","timestamp":1595893821000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-013-6987-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["6987"],"URL":"https:\/\/doi.org\/10.1007\/s00415-013-6987-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,8]]}}}